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Abstract: The search for bioactivities influencing the human wellbeing of food proteins and peptides
is a topic of broad and current interest. γ-Conglutin (γC) is a lupin seed protein drawing remarkable
pharmacological and/or nutraceutical interest, as it is able to reduce hyperglycemia in humans and
animal models. The present work deepens our investigations to understand the molecular basis of
the in vitro effects of γC by testing the possible metabolic effects on cultivated Caco-2 cells. γC and
its derived peptides (obtained via simulated gastrointestinal digestion) did not influence the cell
viability at incubation times up to 24 h. The incubation of cells with native or digested γC caused
no detectable inflammation processes mediated by Nuclear Factor kappa B (NFκB). We checked if
treatment with γC or its derived peptides can elicit the expression of two peptide transporters (Pept-1
and Htp-1) by using an RT-qPCR approach. Native γC caused the halving of Pept-1 expression
compared to untreated cells, but this effect disappeared when γC was digested. Either native γC or
γC peptides reduced the expression levels of Hpt-1. Finally, this work also sheds light on the possible
structural modifications of γC that may occur in the gastrointestinal tract, using an in vitro simulated
dispersed system with polystyrene nanoparticles (NPs).
Keywords: γ-conglutin; seed proteins; bioactive proteins; structure/function relationships; Lupinus albus
1. Introduction
γ-Conglutin (γC) from Lupinus albus, a legume plant widely used in human nutrition, accounts
for 3%–4% of total seed proteins and is a tetrameric glycoprotein [1]. Each monomer is formed by two
polypeptide chains of about 30 and 17 kDa, linked by a disulphide bond derived from a single precursor.
The larger subunit is glycosylated. According to the deduced amino acid sequence (UniProtKB/TrEMBL
accession number: Q9FSH9 LUPAL), its theoretical molecular weight is 45,446 Da and its pI is 8.24 [2].
γC has created remarkable pharmacological and/or nutraceutical interest. It was proven to
significantly decrease glycaemia in animals and humans when orally administered [3–5] and to modify
the gene expression of enzymes involved in hepatic glucose production [6,7]. The glucose-lowering
effect of the protein was comparable to that obtained with metformin, the most commonly prescribed
drug to treat patients suffering from prediabetes. The applicative repercussions of these findings are
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relevant, since lupin seeds are a common component of the Mediterranean diet [8], and thus γC might
complement pharmacotherapy in the management of glucose intolerance [9].
Experiments using mouse myoblasts demonstrated that γC causes the activation of the same
intracellular kinases of the insulin signaling cascade [10], suggesting a possible therapeutic indication
for γC as an insulin-mimetic agent. γC was found accumulated inside the cytosol of the human model
cells, such as Caco-2 monolayers and cultivated HepG2 [11,12]. The protein was also detected inside
intestinal everted sacs [11]. In all these cases, the protein was found in an intact form. These findings
indicate that γC may be translocated across the intestinal barrier.
It has been recently shown that γC has a high affinity with model phospholipid membranes [13].
This suggests that the protein may also interact with other hydrophobic systems. These interactions
can entail the conformational remodeling of the protein structure with possible repercussions on its
functionality. An in vitro simulation of in vivo conditions is usually achieved by reproducing the
typical molecular crowding occurring in a biological system, depending on whether the environment
is a cell or a food system. In such a complex system where proteins and peptides often exert their
functions when inserted into macromolecular structures (such as protein complexes or membranes),
or in food systems (when associated with dispersion phases), protein unfolding and misfolding is
quite usual, whether incidental or induced. The balance between the loss and the gain of functions
plays a crucial role in defining the protein’s molecular properties. The list of these properties is quite
large, ranging from the in vivo proteotoxicity of misfolded proteins, to immunoreactivity, to altered
techno-functional properties [14–17]. The stable adhesion of proteins to hydrophobic structures, such as
nanoparticles (NPs) or nanoemulsions, is a way to mimic these complex systems [18,19]. NPs lead to
conformational changes in proteins, permitting an exposure to new epitopes and, in general, a change
in avidity capacity. Not only does the NP/protein stability vary according to the type of biological
fluid in which they stay, but the protein concentration around the nanobeads also affects the binding
reaction [20,21].
The present work continues past investigations on the cellular mechanisms underlying in vitro
effects, focusing on the possible metabolic effects of the protein using cultivated Caco-2 cells, and shedding
light on the possible structural modifications of γC that may occur when the protein reaches the
gastrointestinal tract, adopting an in vitro simulated dispersed system using polystyrene NPs.
2. Materials and Methods
Reagents were from Sigma-Aldrich (Milan, Italy), if not otherwise specified. Polystyrene
nanoparticles (diameter 200 nm, 2.5% (w/v) suspension) were from Kisker Biotech GmbH and Co.
(Steinfurt, Germany).
2.1. Cell Cultures
Caco-2 cells were grown in 75 cm2 flasks at 37 ◦C in a humidified atmosphere of 6% CO2 in the air,
using Dulbecco’s Modified Eagle’s Medium (DMEM) containing 10% fetal bovine serum (previously
inactivated at 56 ◦C for 30 min), 2 mM L-glutamine, 100 U mL−1 penicillin, and 0.1 mg mL−1 streptomycin.
The day before transfection, cells were seeded in 24-well plates at a density of 2 × 105 cells cm−2.
Cells were transiently transfected with pNiFty2-Luc plasmids (InvivoGen, Rho, Italy) using the StoS
transfection kit (GeneSpin, Milan, Italy), following the supplier’s protocol. After transfection, the cells
were incubated in a complete DMEM medium in the presence of 80 µg mL−1 zeocin (InvivoGen)
for 24 h at 37 ◦C in a humidified atmosphere of 6% CO2 in the air. Transfected Caco-2 cells were
then incubated in 0.2 mL of fresh DMEM containing γC or NPs or a γC/NP complex at the indicated
amounts. Interleukin 1β (IL1β) was used as a positive effector control at a final concentration of
10 ng mL−1. After 4 h, the multi-well plates were chilled for 15 min on ice, and then the cells were
scraped from the bottom of the wells. The complete contents of each well were transferred into 1.5 mL
test tubes placed on ice and sonicated three times for ten seconds using a Soniprep 150 Ultrasonic
Disintegrator (MSE, Fisher Scientific, Loughborough, UK). After centrifugation to remove cell debris,
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a 0.1 mL aliquot of each supernatant was transferred into a 96-well microtiter plate well, and ATP
and d-luciferin were added (final concentrations: 1.20 mM and 12 µM, respectively). The emitted
luminescence was monitored every 120 s using a Victor3 Multilabel Counter (PerkinElmer, Waltham,
MA, USA) at 560 nm. Each sample was analyzed in triplicate, using two biological replicas.
2.2. Cell Vitality Assays
The viable cell number was determined using a Cell Growth Determination Kit (Merck, cat.
CGD1) on a 96-well multiplate according to the manufacturer’s instructions. This method is based
on a (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction, operating via
mitochondrial dehydrogenase to form insoluble formazan, which was then spectrophotometrically
determined at 570 nm upon solubilization with acidified isopropanol [22]. Each sample was analyzed
in triplicate using two biological replicas.
For direct counts, cells were collected after peptide or protein treatment from multiplate wells
using 0.4 mL cm−2 of trypsin/EDTA solution (Sigma-Aldrich, cat. T3924, Milano, Italy) and incubated
at 37 ◦C for 5 min. Then, the suspension was place into a 1.5 mL tube, centrifuged at 15,000× g at RT
(Eppenforf 5415R centrifuge equipped with an F24-15-11 fixed angle rotor), and the supernatant was
discarded. Cells were resuspended in 1 mL of DMEM. Cell suspension aliquots were mixed with an
equal volume of 0.4% Trypan Blue solution (w/v) (Sigma-Aldrich cat. 93595) in a test tube. Ten µL were
placed on a TC20 Automated Cell Counter (Bio-Rad, Hercules, CA, USA) for automatic counting.
2.3. Gene Expression Relative Quantification
Caco-2 cells plated in a 24 well-plate, were raised to confluence and then treated for 3 h with
0.5 mg/mL of different protein samples (digested and not-digested). After incubation, the cells were
lysed to extract the mRNA by using an Aurum total RNA kit, according to the manufacturer’s protocol
(Bio-Rad, Hercules, CA, USA). The mRNA was retro-transcripted using iScript Reverse Transcription
Supermix (Bio-Rad). Each cDNA (2 µL from the previous step) was amplified and quantified via
real time PCR. Reactions were established in a final volume of 20 µL using iQ SYBR Green Supermix
(Bio-Rad), with each primer added to a final concentration of 0.25 µM. The primer was designed by
using the full sequences of pept-1 (5′-caaattaagatggttacgaggg-3′ and 5′-gaagatcgggaccatgatcacg-3),
htp-1 (5′-acagactttgaggagagggcg-3′ and 5′-cagaagggtggtcagcagtatacc-3′), and the housekeeping actin
as normalizer genes (5′-gcaccacaccttctacaatgag-3′ and 5′-tcacgcacgatttcccgctc-3′) [23–25]. The cycling
conditions were as follows: 1 cycle at 95 ◦C for 5 min; 45 cycles of 95 ◦C for 20 s, 55 ◦C for 20 s, and 68 ◦C
for 20 s. A no-template control with no genetic material and no retro-trascripted RNA was included to
exclude contaminations or nonspecific reactions. Relative quantifications were calculated according to
the Livak method [26], setting the gene expression levels of the untreated cells to 1.
2.4. Preparation of γC Samples and Interaction with Nanoparticles
γC was prepared to homogeneity as previously described [9], lyophilized, and stored at 4 ◦C in a
desiccator. Before use, the protein was dissolved to a concentration of about 2 mg mL−1 in a sodium
phosphate buffer of 50 mM, pH 7.3, or in sodium acetate buffer of 50 mM, pH 4.5, depending on the
experimental conditions necessary for subsequent experimentation. The solution was centrifuged
for 10 min at 15,000× g and precisely quantified spectrophotometrically at 280 nm, according to [27].
Sample tests were prepared using a γC final concentration of 0.5 mg mL−1 and increasing amounts
of polystyrene nanoparticles (0.25, 0.50, 0.75, 1.00, and 1.50 mg) in the appropriate buffer. A control
without the addition of nanoparticles was also prepared. Binding between γC and NPs was fostered by
incubation of the samples at 25 ◦C at different times, with continuous gentle stirring. Then, the samples
were centrifuged at 15,000× g for 30 min. Supernatants and precipitates were separated and analyzed,
as described below.
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2.5. SDS-PAGE
SDS-PAGE [28] was carried out as described on 12.5% polyacrylamide gels using a mini-Protean III
cell (Bio-Rad, Hercules, CA, USA). Runs were carried out at a constant 16 mA for each gel. Polypeptides
were visualized by Coomassie Brilliant Blue staining. The relative molecular weight of the polypeptides
was determined by comparison with the standard proteins (GE-Healthcare, Milan, Italy) containing
phosphorylase b (94 kDa), bovine serum albumin (67 kDa), egg albumin (45 kDa), carbonic anhydrase
(29 kDa), trypsin inhibitor (20 kDa), and lysozyme (14 kDa).
Supernatants were analyzed as such, whereas pelleted NPs were resuspended at their initial
volume with the appropriate buffer. Samples were mixed with an equal volume of the sample buffer
(0.25 M Tris-HCl, pH 6.8, 7.5% glycerol, 2% SDS, and 2% β-mercaptoethanol) and heated at 100 ◦C for
5 min prior to being loaded onto the gel.
2.6. Proteolytic Digestions
Simulated gastrointestinal digestion was carried out by adapting a procedure previously
described [29], focusing the action only on the proteolytic phase. Freeze-dried γC was resuspended
(1 mg mL−1) in sterile water adjusted to pH 2 with 1 M HCl. Pepsin (Sigma-Aldrich, cat. P7012) was
dissolved (0.5 mg/mL) in 10 mM Tris-HCl buffer, pH 6.5, containing 150 mM NaCl and added to protein
samples at a ratio of 1:100. The samples were incubated at 37 ◦C for 10 min under shaking. After that,
the pH was adjusted to 8 with a 1 M NaOH solution, and porcine pancreatin was added to samples
at a ratio of 1:100. The samples were shaken again at 37 ◦C for 10 min. At the end, the reaction was
stopped with a protease inhibitor cocktail (Sigma-Aldrich, cat. P8340).
For experiment with NPs, γC (0.5 mg) and 30 µL of the NP suspension were incubated in one mL
of Tris-HCl 50 mM buffer at pH 8.0, at 20 ◦C for 30 min, with occasional gentle stirring. Samples were
then centrifuged for 30 min at 15,000× g, and the supernatants were separated from the precipitate.
To 250 µL of supernatant, 40 µL of trypsin stock (0.05 mg/mL, prepared in 2 mM HCl/NaCl, pH 3.0)
was added. Instead, the precipitate was resuspended in 250 µL of Tris-HCl 50 mM buffer, pH 8.0,
and 10 µL of trypsin stock was added. The sample control was prepared in the same way, without
the addition of NPs. 50 µL of trypsin stock was added to the 250 µL control solution. Sample were
incubated at 20 ◦C for different times (0, 15, 30, 45, and 60 min). The trypsin reaction was stopped by
adding an equal volume of an electrophoresis sample buffer and rapid heating at 100 ◦C for 10 min,
before SDS-PAGE was performed.
2.7. Protein Densitometric Quantification
The amount of each polypeptide separated by SDS-PAGE was quantified after CBB staining
by computer-assisted image densitometry. Band intensities were determined using the open source
software ImageJ (ver. 150e, National Institutes of Health, Bethesda, MD, USA), available at https:
//imagej.net/ImageJ [30], and expressed as arbitrary units. All determinations were carried out in
triplicate, and the results were given as the mean ± standard error.
2.8. In-Silico Predictions
Prediction of the peptides’ toxicity was carried out using the ToxinPred method [31], available
on-line at http://crdd.osdd.net/raghava/toxinpred/, using the Uniprot KB: Q9FSH9 amino acid sequence
of γC as a template.
2.9. Statistical Analysis
Data reported in the histograms are expressed as the means ± S.E. Data were analyzed by a t-test.
p values < 0.05 were considered to be statistically significant. Data from RT-qPCR were analyzed by
using the CFX Maestro software (Bio-Rad, Hercules, CA, USA).
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3. Results and Discussion
As stated before, many aspects of the possible bioactivities of γC on model human cells have yet
to be further elucidated. We focused on the effects on the Caco-2 cell, since previous works on the
subject have been carried out using this cell model [11]. Caco-2 is a cell line derived from human colon
adenocarcinoma used as a common model of the intestinal barrier for in vitro toxicology studies and
to test the biological activities of food-derived molecules [32].
3.1. Cytotoxicity Assessments
Previous works have shown, by confocal microscopy and TEM, that γC aggregates stack onto the
cell membranes and are found inside the cytoplasm in an intact form [12]. This may be the prerequisite
for exerting a biological function, but possible parallel negative effects cannot be excluded. We verified
whether any cytotoxicity of γC towards Caco-2 cells could became evident at incubation times up to
24 h, since, in previous works, incubations were generally limited to 3 or 6 h of protein/cell contact. Cell
loss and metabolic activities were assessed using Tryphan Blue (TB) and 3-[4–dimethylthiazol-2-yl]-2,5-
diphenyltetrazolium bromide (MTT). The results are shown in Figure 1. No significant losses were
visible, indicating that γC itself does not influence the cell’s viability at prolonged incubation times
(Figure 1A). Moreover, it was clearly established that ingested food proteins may release toxic peptides
following the digestion process [33,34]. In-silico prediction indicated that some regions ofγC, located on
the large subunit at positions around 180–196, can generate potentially toxic peptides (Supplementary
Materials, Figure S1). However, our experimental results seem to exclude this evidence. Indeed,
when Caco-2 cells were treated with the peptides obtained by the in vitro-simulated gastro-intestinal
digestion of γC, no negative effects were observed (Figure 1B).
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Figure 1. Assessment of Caco-2 cell vitality following treatment with native γC (A) and with γC-derived
peptides (B) using the 3-[4–dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) method and
direct cell counting (Tryphan Blue (TB)). Data are expressed as a percentage of the control sample.
3.2. γC Effects on Inflammatory Pathways
The possible effects of γC on inflammation cell pathways has been studied by using transfected
Caco-2 cell expressing markers of the immune responses triggered by interleukin 1 beta (IL1β)
through the activation of the nuclear factor kappa B (NFκB) pathway [35]. NF-κB is implicated in
many physiological processes, such as the innate and adaptive immune response, cell death, and
inflammation. It also activates cytokine transcription. The results reported in Figure 2 show that
the incubation of Caco-2 cells with native or in-vitro digested γC caused no detectable inflammation
processes. This indicates that the protein or its proteolytic breakdown peptides are not able to mime
IL1β stimulation (that is, they do not activate the NFkB pathway). On the other hand, if the cells were
incubated with IL1β, the presence of either γC or peptides did not influence the inflammatory process.
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Figure 2. Effects on the Caco-2 transfected cell nuclear factor kappa B (NFκB) pathway of γC and of its
peptides derived from simulated gastrointestinal digestion (pept). Experimental details are given in
the text. Blanks are Caco-2 cells incubated alone (negative control), whereas IL are cells incubated with
Interleukin 1β (IL1β) (positive control). γC and pept have been also been incubated in the presence of
IL1β (+IL).
3.3. Effects on the Expression of Intestinal Peptide Transporters
The addition of a protein to the incubation medium could have repercussions on the metabolism
of the cells. We checked if treatment with γC or its derived peptides can elicit, on Caco-2 cells,
the expression of two main peptide transporters (Pept-1 and Htp-1) by using an RT-qPCR approach.
The results are shown in Figure 3. Cells were also treated with chicken ovalbumin (OVA) and bovine
serum albumin (BSA), at the same concentration (0.5 mg mL−1), for comparison and to exclude generic
aspecific artifacts. It has been well esthablished that incresing the protein concentration influences the
transcription and activity of these transporters [36–38]. A comparison between intact and hydrolyzed
proteins was also made using the same final protein concentration (0.5 mg mL−1).Biomolecules 2019, 9, x 7 of 13 
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γC, determined by RT-qPCR. (A) Expression modulation of the Pept-1 transporter. (B) Expression
odulation of the pt-1 transporter. Chicken ovalbu in (OVA) and bovine seru albu in (BSA)
were also tested. Proteins have bee tested in native conditions and after si ulated gastrointestinal
digestion (GI ). Caco-2 are untreated cells.
Pept-1 is an oligopeptide transporter lo ated on the cellular membrane of Caco-2 and other human
intestinal cells [36], whose expression is increased by several kinds of molecules but not insulin. Rather,
this hormone stimulates peptide transport by increasing the amount of Pept-1 on the membranes
from a preformed cytoplasmatic pool [39]. γC shares common effects with insulin, as it is able to
regulate gene expression, energy metabolism, and protein synthesis through the modulation of the
same insulin signalling pathways [10]. Interestingly, the presence of γC in the medium caused the
halving of the transporter expression recorded in untreated cells (Figure 3A). On the other hand,
this effect desappears when γC is digested, with expression levels similar to those of the control cells.
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Either native or digested OVA and BSA have no significant consequences on the expression of Pept-1
under the adopted experimal conditions. The fact that native γC shows the downregulation of Pept-1
is surprising and intriguing, since it is not one of the expected effects of any molecule described, so far,
as an insulin analog [4,10,39]. Peptides that are generated by the simulated gastrointestinal digestion
of the three proteins are not able to modulate Pept-1 expression. However, the possible translocation
of the preformed Pept-1 to the cell’s apical membranes cannot be excluded [38]. However, in light of
these results, consequences due to cell growth conditions may be ruled out [40].
Hpt-1, the second main peptide transporter, is expressed on apical membranes in Caco-2 cells
and is also known as cadherin CDH17 [27]. Aberrant expressions of CDH17 have been associated
with cancer development and progression [41]. Our results (Figure 3B) indicate that treatment with
either native γC or γC peptides reduced the expression level of Hpt-1, and, meanwhile, the intact
OVA and BSA have no influence. Digested BSA peptides seem to exert a slight downregulation of this
transporter. Whether these data are relevant for tumor prevention or progression issues has yet to be
established and needs future, more, focused investigations.
3.4. γC molecular Features and Biological Effects Following Adsorbtion to Polystyrene NPs
As the first trial, we tested the binding properties of γC to NPs. Total of 30 µL (0.75 mg) of NP
suspension was added to 0.5 mg of protein and incubated, at pH 7.3, at room temperature for 45
min. After centrifugation, both the supernatant and the precipitated NPs were analyzed. SDS-PAGE
(Figure 4A) showed that the protein effectively interacted with NPs. The adsorption was quite fast
and stable over time. By incubating the samples at different time intervals (1, 2, 5 h, and overnight),
the amount of bound γC (i.e., the decrease of soluble unbound γC in the supernatant, detected by
spectrophotometric reading at 280 nm) did not vary significantly (Figure 4B).
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To quantify the observed binding, increasing amounts of nanoparticles (0.25, 0.50, 0.75, 1.00,
and 1.50 mg) were mixed with a fixed amount of γC (0.5 mg) in one mL of an appropriate buffer and
incubated for one hour, as described above. After centrifugation, the bound protein was calculated
by its difference from the amount of unbound protein soluble in the supernatant (Figure 5). γC is
adsorbed onto the hydrophobic surface of NPs according to a linear correlation.
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At pH 7.3, where the protein is tetrameric, the adsorption ratio is 115 ± 10 µg of protein per mg of
NPs. If γC is instead adsorbed to NPs in an acetate buffer (pH 4.5), where it is in a monomeric for ,
the binding ratio reduced to 43 ± 6 µg of protein per mg of NPs, which is about half of that bound at
pH 7.3. Hypothesizing that, at both pHs, the NP surface is saturated by proteins, these results suggest
that at acidic pHs, γC is adsorbed as a monolayer onto hydrophobic NPs. Conversely at a neutral pH,
taking advantage of its multimeric form, a bilayer structure is likely assembled. On the other hand,
on a stoichiometric basis, more protein is bound to NPs in an acidic pH.
Different methodologies can be adopted to verify the possible conformational changes of γC
following its adsorption to polystyrene nanoparticles. γC shows a rather unusual resistance to
proteases, both during seed germination processes and in in vitro tests [42]. At pH values below 4.25,
a relevant rearrangement of the protein conformation occurs [1], resulting in a marked susceptibility
of γC to enzymatic hydrolysis, while it is completely resistant to various proteolytic enzymes and
protease mixtures at higher pH values. Thus, trypsin was used to assess the possible conformational
changes of γC following its adsorption to NPs. This experimental approach has been successfully
applied in previous works testing the structural variations of γC [43]. After adsorption, γC/NPs were
incubated with trypsin for up to 24 h (Figure 6).
The am nt of protein bound to NPs decreased during the treatment (Figure 6A), indicating
th t trypsin can act on imm bilized γC. As expected, trypsin did not digest native protein in the
solution without NPs (Supplementary Materials, Figure S2). No breakdown products are visible as
discrete bands on the SDS-PAGE (Supplementary Materials, Figure S2B), at least for the NP-bound
protein or the protein alone after 60 min of incubation with trypsin. The adsorbed γC, being more
digestible than the native protein, likely takes a less compact tertiary structure than the protein in the
solution (Figure 3B). The 17 kDa subunit of γC is more accessible to trypsin than the 30 kDa subunit
(Figure 3B). Overall, these results allow us to depict a possible sequence of events. Binding to NPs leads
to conformational changes of the protein, giving access to regions of the polypeptide chain containing
buried K and R residues that are otherwise inaccessible to the protease mainly located on the small
subunit and opening the way to an advanced level of enzymatic digestion. Whether digestion modifies
the capacity of γC to interact with the hydrophobic surface of NPs remains to be directly established,
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even if no significative differences were recorded in the amounts of soluble γC released from γC/NPs
during the time course of the enzymatic treatment.
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Figure 6. The adsorbed γC’s sensitivity to trypsin and its constituent subunits. (A) A relative amount
of γC remained bound to the NPs over time; (B) the digested fraction of 30 kDa (white bars) and of 17
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The possible variations of the biological properties of γC have been assessed by checking
the possible inflammatory/anti-inflammatory properties of the transfetted Caco-2 cells variations.
The results are shown in Figure 7.
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experimental details. Blank areas are the Caco-2 cells incubates alone (negative control), whereas IL is
the cells incubated with IL1β (positive control).
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This pro-inflammatory effect appears to be dose dependent; by doubling the quantity of NPs,
the inflammation increased twice. NPs made of ifferent materials showed a similar effect in their
fibrobl sts, macrophages, and bronchiolar epithelial cells, as previously described [44]. Interestingly,
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4. Conclusions
In the last few years, the research of bioactive proteins and peptides derived from foods has
increased. Our studies on γC fit into this workflow. The new findings reported in the present work
are relevant to delineating a deeper understanding of the metabolic fate of orally administered γC
and addressing its applicative exploitation. Of course, our results open the way to further studies
aimed at ascertaining the precise molecular determinants underlying the hypoglycemic activity of
γC. Moreover, this study adds one piece to the puzzle of the possible uses of nanomaterials in food
systems. Hydrophobic polystyrene NPs have been proven to be pro-inflammatory for Caco-2 cells.
γC-coated NPs completely lose this negative trait, suggesting that the nanometric dimensions, per se,
are not responsible for NFkB pathway stimulation and underscore the relevance of the NPs’ nature.
From a methodological point of view, it must be underscored that working with NPs does not
allow one to apply the usual spectroscopic techniques (such as spectroscopy, spectrofluorimetry,
and spectropolarimetry) to characterize the protein’s structural features. Consequently, all this
information must be acquired by indirect approaches. For example, in this work, the amount of
NP-bound protein was quantified by its difference to the protein fraction that does not bind to the NPs.
Again, the protein’s susceptibility to hydrolysis with trypsin was employed as a structural probing tool.
Taken together, our results show that the spontaneous adsorption of γC onto a hydrophobic surface
goes alongside a rearrangement of the protein’s structure, which changes the reactivity of the protein.
The resulting NP-protein corona, with respect to the native protein, has distinctive features that affect
degradation and, more important to our studies, inflammation [45].
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/2218-273X/9/10/606/s1.
Figure S1: Prediction of peptides toxicity calculated by using the ToxinPred method [31], available on-line at
http://crdd.osdd.net/raghava/toxinpred/, using Uniprot KB:Q9FSH9 amino acid sequence of γC as template,
Figure S2: Panel A: native γC incubated with trypsin for different times. Panel B: Incubation with trypsin effects
on γC adsorbed to NPs.
Author Contributions: A.S., A.B., and J.C. designed the experiments; J.C., S.M., and M.G. performed the
experiments; A.S., A.B., and J.C. analyzed the data; A.S. and A.B. wrote the paper.
Funding: J.C. was supported by Università degli Studi di Milano (Assegno di Ricerca tipo A, 2015-PDF-0144).
Acknowledgments: The authors are grateful to Stefania Arioli for her assistance with luminometer determinations.
Conflicts of Interest: The authors declare no conflict of interest.
Abbreviations
NPs Nanoparticles
γC γ-Conglutin
MTT
3-[4–dimethylthiazol-2-yl]-2,5-diphenyltetrazolium
bromide
NFkB Nuclear Factor kappa B
TB Tryphan Blue
IL1β Interleukin 1β
References
1. Capraro, J.; Spotti, P.; Magni, C.; Scarafoni, A.; Duranti, M. Spectroscopic studies on the pH-dependent
structural dynamics of γ-conglutin, the blood glucose-lowering protein of lupin seeds. Int. J. Biol. Macromol.
2010, 47, 502–507. [CrossRef] [PubMed]
2. Scarafoni, A.; Di Cataldo, A.; Vassilevskaia, T.D.; Bekman, E.P.; Rodrigues-Pousada, C.; Ceciliani, F.;
Duranti, M. Cloning, sequencing and expression in the seeds and radicles of two Lupinus albus conglutin
gamma genes. Biochim. Biophys. Acta 2001, 1519, 147–151. [CrossRef]
Biomolecules 2019, 9, 606 11 of 13
3. Magni, C.; Sessa, F.; Accardo, E.; Vanoni, M.; Morazzoni, P.; Scarafoni, A.; Duranti, M. Conglutin gamma, a
lupin seed protein, binds insulin in vitro and reduces plasma glucose levels of hyperglycemic rats. J. Nutr.
Biochem. 2004, 15, 646–650. [CrossRef] [PubMed]
4. Bertoglio, J.C.; Calvo, M.A.; Hancke, J.L.; Burgos, R.A.; Riva, A.; Morazzoni, P.; Ponzone, C.; Magni, C.;
Duranti, M. Hypoglycemic effect of lupin seed γ-conglutin in experimental animals and healthy human
subjects. Fitoterapia 2011, 82, 933–938. [CrossRef]
5. Lovati, M.R.; Manzoni, C.; Castiglioni, S.; Parolari, A.; Magni, C.; Duranti, M. Lupin seed γ-conglutin
lowers blood glucose in hyperglycaemic rats and increases glucose consumption of HepG2 cells. Br. J. Nutr.
2012, 107, 67–73. [CrossRef]
6. Vargas-Guerrero, B.; García-López, P.M.; Martínez-Ayala, A.L.; Domínguez-Rosales, J.A.; Gurrola-Díaz, C.M.
Administration of Lupinus albus gamma conglutin (Cγ) to n5 STZ rats augmented Ins-1 gene expression and
pancreatic insulin content. Plant Foods Hum. Nutr. 2014, 69, 241–247. [CrossRef]
7. González-Santiago, A.E.; Vargas-Guerrero, B.; García-López, P.M.; Martínez-Ayala, A.L.; Domínguez-Rosales, J.A.;
Gurrola-Díaz, C.M. Lupinus albus conglutin gamma modifies the gene expressions of enzymes involved in
glucose hepatic production in vivo. Plant Foods Hum. Nutr. 2017, 72, 134–140. [CrossRef]
8. Scarafoni, A.; Magni, C.; Duranti, M. Molecular nutraceutics as a mean to investigate the positive effects of
legume seed proteins on human health. Trends Food Sci. Technol. 2007, 18, 454–463. [CrossRef]
9. Lacroix, I.M.E.; Li-Chan, E.C.Y. Overview of food products and dietary constituents with antidiabetic
properties and their putative mechanisms of action: A natural approach to complement pharmacotherapy in
the management of diabetes. Mol. Nutr. Food Res. 2014, 58, 61–78. [CrossRef]
10. Terruzzi, I.; Senesi, P.; Magni, C.; Montesano, A.; Scarafoni, A.; Luzi, L.; Duranti, M. Insulin-mimetic action
of conglutin-γ, a lupin seed protein, in mouse myoblasts. Nutr. Metab. Cardiovasc. Dis. 2011, 21, 197–205.
[CrossRef]
11. Capraro, J.; Clemente, A.; Rubio, L.A.; Magni, C.; Scarafoni, A.; Duranti, M. Assessment of the lupin
seed glucose-lowering protein intestinal absorption by using in vitro and ex vivo models. Food Chem.
2011, 125, 1279–1283. [CrossRef]
12. Capraro, J.; Magni, C.; Faoro, F.; Maffi, D.; Scarafoni, A.; Tedeschi, G.; Maffioli, E.; Parolari, A.;
Manzoni, C.; Lovati, M.R.; et al. Internalisation and multiple phosphorylation of γ-conglutin, the lupin seed
glycaemia-lowering protein, in HepG2 cells. Biochem. Biophys. Res. Commun. 2013, 437, 648–652. [CrossRef]
[PubMed]
13. Scirè, A.; Baldassarre, M.; Tanfani, M.; Capraro, J.; Duranti, M.; Scarafoni, A. Interaction of γ-conglutin
from Lupinus albus with model phospholipid membranes: Investigations on structure, thermal stability and
oligomerization status. Biochim. Biophys. Acta 2018, 1866, 1242–1248. [CrossRef] [PubMed]
14. Brehme, M.; Voisine, C. Model systems of protein-misfolding diseases reveal chaperone modifiers of
proteotoxicity. Dis. Models Mech. 2016, 9, 823–838. [CrossRef] [PubMed]
15. Marengo, M.; Miriani, M.; Ferranti, P.; Bonomi, F.; Iametti, S.; Barbiroli, A. Structural changes in
emulsion-bound bovine beta-lactoglobulin affect its proteolysis and immunoreactivity. Biochim. Biophys.
Acta 2016, 1864, 805–813. [CrossRef]
16. Kristo, E.; Corredig, M. Functional Properties of Food Proteins. In Applied Food Protein Chemistry; Ustunol, Z.,
Ed.; John Wiley & Sons, Ltd.: West Sussex, UK, 2015; pp. 47–73. [CrossRef]
17. Stefani, M. Protein folding and misfolding on surfaces. Int. J. Mol. Sci. 2008, 9, 2515–2542. [CrossRef]
18. Miriani, M.; Eberini, I.; Iametti, S.; Ferranti, P.; Sensi, C.; Bonomi, F. Unfolding of beta-lactoglobulin
on the surface of polystyrene nanoparticles: Experimental and computational approaches. Proteins
2014, 82, 1272–1282. [CrossRef]
19. Miriani, M.; Iametti, S.; Kurtz, D.M.; Bonomi, F. Rubredoxin refolding on nanostructured hydrophobic
surfaces: Evidence for a new type of biomimetic chaperones. Proteins 2014, 82, 3154–3162. [CrossRef]
20. Nel, A.E.; Mädler, L.; Velegol, D.; Xia, T.; Hoek, E.M.; Somasundaran, P.; Klaessig, F.; Castranova, V.;
Thompson, M. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater.
2009, 8, 543–557. [CrossRef]
21. Bekdemir, A.; Liao, S.; Stellacci, F. On the effect of ligand shell heterogeneity on nanoparticle/protein binding
thermodynamics. Colloids Surf. B Biointerfaces 2019, 174, 367–373. [CrossRef]
Biomolecules 2019, 9, 606 12 of 13
22. Denizot, F.; Lang, R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium
dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 1986, 89, 271–277. [CrossRef]
23. Walker, D.; Thwaites, D.T.; Simmons, N.L.; Gilbert, H.J.; Hirst, B.H. Substrate upregulation of the human
small intestinal peptide transporter, hPepT1. J. Physiol. 1998, 507, 697–706. [CrossRef] [PubMed]
24. Dantzig, A.H.; Hoskins, J.A.; Tabas, L.B.; Bright, S.; Shepard, R.L.; Jenkins, I.L.; Duckworth, D.C.;
Sportsman, J.R.; Mackensen, D.; Rosteck, P.R., Jr.; et al. Association of intestinal peptide transport with a
protein related to the cadherin superfamily. Science 1994, 264, 430–433. [CrossRef] [PubMed]
25. Behrens, I.; Kissel, T. Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2
cell monolayers? Eur. J. Pharm. Sci. 2003, 19, 433–442. [CrossRef]
26. Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods 2001, 25, 402–408. [CrossRef]
27. Duranti, M.; Sessa, F.; Scarafoni, A.; Bellini, T.; Dallocchio, F. Thermal stabilities of lupin seed conglutin γ
protomers and tetramers. J. Agric. Food Chem. 2000, 48, 1118–1123. [CrossRef]
28. Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature
1970, 227, 680–685. [CrossRef]
29. Brodkorb, A.; Egger, L.; Alminger, M.; Alvito, P.; Assunção, R.; Balance, S.; Bohn, T.; Bourlieu-Lacanal, C.;
Boutrou, R.; Carrière, F.; et al. INFOGEST static in vitro simulation of gastrointestinal food digestion.
Nat. Protoc. 2019, 14, 991–1014. [CrossRef]
30. Schneider, C.A.; Rasband, W.S.; Eliceiri, K.W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods
2012, 9, 671–675. [CrossRef]
31. Gupta, S.; Kapoor, P.; Chaudhary, K.; Gautam, A.; Kumar, R.; Open Source Drug Discovery Consortium;
Raghava, G.P. In silico approach for predicting toxicity of peptides and proteins. PLoS ONE 2013, 8, e73957.
[CrossRef]
32. Lea, T. Caco-2 Cell Line. In The Impact of Food Bioactives on Health: In Vitro and Ex Vivo Models; Verhoeckx, K.,
Cotter, P., López-Expósito, I., Kleiveland, C., Lea, T., Mackie, A., Requena, T., Swiatecka, D., Wichers, H.,
Eds.; Springer International Publishing: Berlin, Germany, 2015; pp. 103–111. [CrossRef]
33. Rutherfurd-Markwick, K.J. Food proteins as a source of bioactive peptides with diverse functions. Br. J. Nutr.
2012, 108, S149–S157. [CrossRef] [PubMed]
34. Nongonierma, A.B.; Fitzgerald, R.J. Strategies for the discovery and identification of food protein-derived
biologically active peptides. Trends Food Sci. Technol. 2017, 69, 289–305. [CrossRef]
35. Lawrence, T. The Nuclear Factor NF-κB pathway in inflammation. Cold Spring Harb. Perspect. Biol.
2009, 1, a001651. [CrossRef]
36. Ferraris, R.P.; Diamond, J.M. Specific regulation of intestinal nutrient transporters by their dietary substrates.
Annu. Rev. Physiol. 1989, 51, 125–141. [CrossRef]
37. Leibach, F.H.; Ganapathy, V. Peptide transporters in the intestine and the kidney. Annu. Rev. Nutr.
1996, 16, 99–119. [CrossRef]
38. Adibi, S.A. The oligopeptide transporter (Pept-1) in human intestine: Biology and function. Gastroenterology
1997, 113, 332–340. [CrossRef]
39. Thamotharan, M.; Bawani, S.Z.; Zhou, X.; Adibi, S.A. Hormonal regulation of oligopeptide transporter Pept-1
in a human intestinal cell line. Am. J. Physiol. Cell Physiol. 1999, 276, C821–C826. [CrossRef]
40. Sambuy, Y.; De Angelis, I.; Ranaldi, G.; Scarino, M.L.; Stammati, A.; Zucco, F. The Caco-2 cell line as a model
of the intestinal barrier: Influence of cell and culture-related factors on Caco-2 cell functional characteristics.
Cell Biol. Toxicol. 2005, 21, 1–26. [CrossRef]
41. Lee, N.P.; Poon, R.T.; Shek, F.H.; Ng, I.O.; Luk, J.M. Role of cadherin-17 in oncogenesis and potential
therapeutic implications in hepatocellular carcinoma. Biochim. Biophys. Acta 2010, 1806, 138–145. [CrossRef]
42. Capraro, J.; Magni, C.; Scarafoni, A.; Duranti, M. Susceptibility of lupin gamma-conglutin, the plasma
glucose-lowering protein of lupin seeds, to proteolytic enzymes. J. Agric. Food Chem. 2009, 57, 8612–8616.
[CrossRef]
43. Duranti, M.; Gius, C.; Sessa, F.; Vecchio, G. The saccharide chain of lupin seed conglutin γ is not responsible
for the protection of the native protein from degradation by trypsin, but facilitates the refolding of the
acid-treated protein to the resistant conformation. Eur. J. Biochem. 1995, 230, 886–891. [CrossRef] [PubMed]
Biomolecules 2019, 9, 606 13 of 13
44. Sohaebuddin, S.K.; Thevenot, P.T.; Baker, D.; Eaton, J.W.; Tang, L. Nanomaterial cytotoxicity is composition,
size, and cell type dependent. Part. Fibre Toxicol. 2010, 7, 22. [CrossRef] [PubMed]
45. Saptarshi, S.R.; Duschl, A.; Lopata, A.L. Biological reactivity of zinc oxide nanoparticles with mammalian
test systems: An overview. Nanomedicine 2015, 10, 2075–2092. [CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
